Mach7 Technologies Ltd. · ASX:M7T

Mach7 Technologies — Bell Potter Healthcare Conference 2026

13 slides from Mach7 Technologies's conference presentation, Nov 17, 2026

  1. Slide 1: ASX Announcement: Bell Potter Healthcare Conference 2026

    ASX Announcement 17 November 2026 For personal use only BELL POTTER HEALTHCARE CONFERENCE 2026 Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX: M7T), a healthcare software company providing a broad set of enterprise imaging solutions for modern, AI-enabled healthcare environments, provide

  2. Slide 2: Forward-looking statements and company details

    ASX Announcement All data presented in this announcement reflects the current views of the Company with respect to future events. Forward-looking statements are subject to risk, uncertainties and assumptions relating to the operations, results of operations, growth strategy and liquidity of the Comp

  3. Slide 3: Bell Potter Healthcare Conference: From archive to architecture

    rsonal use only Bell Potter Healthcare Conference From archive to architecture Mach7 Technologies Limited | ASX: M7T | November 2026

  4. Slide 4: Disclaimer and forward looking statements

    Disclaimer “Forward looking” statements Summary of information: This presentation contains general and background information about Mach7 and should not be relied on as an indication or guarantee of future performance and involve known and Technologies Limited (“M7T”) activities current as at the da

  5. Slide 5: From archive to architecture

    rsonal use only FR OM AR CHIV E TO A RCH ITECT URE We complete the patient picture with the patient's pictures. Imaging data, unified, organised, and secure wherever care happens; and integrated with the Electronic Health Record1 under the customer's control. “ From Pixel to Point of Care.” 1. An El

  6. Slide 6: Our steps to growth, in order of speed to revenue

    Our steps to growth, in order of speed to revenue rsonal use only 1. Protect and expand the installed base 2. Win new customers Existing customer growth is the fastest revenue available to us. We have Targeting well-aligned prospects with products we deliver today, helped by large blue-chip customer

  7. Slide 7: Increased pace and volume of development on a lower cost base

    Increased pace and volume of development on a lower cost base rsonal use only 2.5x Q1 FY27 capitalised development vs pcp 4.4x AI-enabled productivity gain Deeper customer engagement directly drives development. I M A G I N G D ATA ENTERPRISE EXECUTION ARCHITECTURE D I AG N O S T I C V I E W I N G V

  8. Slide 8: Flamingo

    Flamingo Foundation rsonal use only Our innovative next-generation A modern core, included as a base to other modules, including expanded architecture: containerised deployment, a DICOM, HL7, FHIR and other APIs. modern, lower-cost database, a unified experience, and new capabilities sold as Storage

  9. Slide 9: Why customers want Flamingo

    Why customers want Flamingo rsonal use only Each module saves money, time or risk on the images and systems customers already have installed. Save money Save time Buy only what you need One worklist across every site Start with one module and add more later. All types of users can read from a single

  10. Slide 10: Q1 FY27 summary: 4th consecutive quarter of positive operating cash flow

    Q 1 F Y 2 7 S U M M A RY 4th consecutive quarter of positive operating cash flow as imaging portfolio advances rsonal use only Cash generation. Mach7 delivers four consecutive quarters of positive operating 1 cash flow for the first time in its history. Receipts of A$7.3M. Up 58% on pcp1 reflecting

  11. Slide 11: A Strategic RSNA

    A Strategic RSNA rsonal use only 29 November to 3 December · McCormick Place, Chicago · Booth 4116 W H AT R S N A I S W H O AT T E N D S The Radiological Society of North America's annual meeting, the 40,000+ attendees from 160 countries, including radiologists, industry's largest global imaging mee

  12. Slide 12: From reset to growth in the imaging data layer

    From reset to growth in the imaging data layer rsonal use only The reset is largely behind us and we are focused on the growth engine. The last two phases reflect the company we are building. L A R G E LY C O M P L E T E N OW NEXT AMBITION Reset and stabilise Prove the growth Compound and lead Own t

  13. Slide 13: Contact Us

    rsonal use only Contact Us Investor Relations, Mach7 Françoise Debelak Dixon +61 (0) 412 292 977 ir@mach7t.com Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 This document was authorised for release to the ASX by Teri Thomas, Managing Director and Chief Executive Officer Ma

Mach7 Technologies — Bell Potter Healthcare Conference 2026 on 6ix